-- Gilead and Genesis Will Leverage the GEMS AI Platform to Generate and Jointly Optimize Molecules Against Selected Targets --
-- Gilead Receives Exclusive Rights to Develop and Commercialize Products from the Collaboration --
https://www.businesswire.com/news/home/20240910912771/en
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.